Next Article in Journal
Synthesis of Mono- and Dibromo-Derivatives of 1-Phenylpyrazol-3-ol
Previous Article in Journal
Synthesis of 4-isopropyl-bis-2,6-morpholin-4-ylmethyl-1-phenol
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molbank
Volume 2007
Issue 3
10.3390/M550
molbank-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

Synthesis of 1,2,5,7-dithiadiazonan-6-ylidenecyanamide. A New Potential Cysteamine Derivate Radioprotector Compound

by
Enrique Angeles
1,*,
Italo Menconi
1,
Alberto Ramírez
1,
Ana María Velázquez
1,
Brígida Camacho
1,
Gerardo Ordónez
1,
Ignacio Martínez
1,
Sandra Díaz-Barriga
1 and
Rafael López-Castañares
2
1
Laboratorio de Química Medicinal, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, México
2
Facultad de Química de la UAEM, Universidad Autónoma del Estado de México
*
Author to whom correspondence should be addressed.
Molbank 2007, 2007(3), M550; https://doi.org/10.3390/M550
Submission received: 19 January 2007 / Accepted: 24 February 2007 / Published: 30 May 2007
Versions Notes

Molbank 2007 m550 i001

Introduction

Radioprotectors have been described as a chemical compounds that protect certain normal tissues as opposed to tumors. [1] and have shown promise for protecting mammals against otherwise lethal effects of ionizing radiation; they are particular interest since they lack nitrogen, wich typically is present in antiradiation agents[2]. The action mechanism of radioprotectors is postulated that they act through their aminothiol derivative wich is libereted in vivo [3,4]. There has been reported in literature the synthesis of many radioprotector that interact with proteins [5] and also enhance its radiorpotective effect [6,7,8].Furthermore, the nucleophilic thiol grups present in radioprotectors, could also trap xenobiotic electrophilic intermediates originating from alkylating agents by formation of cavalent bonds.On the other hand some ciclic cysteamine radiportector realted compounds have been (I-IV) (Fig. 1).
1,2,5,7-dithiadiazonan-6-ylidenecyanamide (3) was prepared from dithiomethylcyanourea (1) and cistamine (2) in methanol as solvent . A solution of methanol (50 mL) and sodium hydroxyde was prepared and 1 (g, mmol) in methanol (mL) was added and heated at 40 °C for 15 minutes, after that a solution of 2 (g, mmol) in methanol was added . When the addition was completed, the reaction mixture was stirred at reflux for 24 hrs. The solvent was eliminated using rotavapor and reaction mixture was poured into water and extracted with ehtyl acetate. The product was crystallized after eliminated solvent and recrystallized from ethanol as white powder (85% yield).
Melting point: 152-154 °C (ethanol, uncorrected).
IR (cm−1; KBr Disk) 3452 (N-H), 2220 (CN), 1609 (C=C).
1H-NMR (300 MHz; CDCl3; Me4Si, δH): 9.50 (2H, s, NH), 3.76 (4H, m, N-CH2-), 3.52 (4H, m, -S-CH2-).
13C-NMR (75 MHz; CDCl3; δC): 177.9 (C=N), 117.6 (CN), 47.42(-N-CH2-), 31.21 (-S-CH2-).
MS m/z (rel %): 202(1.0 %), 172 (100%)
Elemental Analysis: Calculated for C6H10N4S2 (202): C 35.62 %, H 4.98 %, N 27.70 %, S 31.77 % ; found : C 35.70 %, H 5.01 %, N 27.56 %, S 31.91 %.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgements

The authors wish to acknowledge to PAPIIT/UNAM Proyect No IN213606 and ALPHARMA SA de CV, by partially support this work. We would like to thank C.Barajas F.Sotres and D.Jiménez for their skillful technical assistance and DGSCA-UNAM for their support. As a part of Proyect Cátedra Química Medicinal of FESC-UNAM.

References

  1. Oiry, J.; Pue, J.Y.; Imbach, J.L.; Fatome, M.; Sentenac-Roumanou, H.; Lion, C.L. J. Med. Chem. 1986, 29, 2217–2225.
  2. Macke, J.D.; Field, L. J. Org. Chem. 1988, 53, 386–402. [PubMed]
  3. Harris, J.W.; Phillips, T.L. Radiat. Res. 1971, 46, 362.
  4. Yuhas, J.M. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8, 513. [CrossRef]
  5. Schwartz, M.A.; Das, O.P.; Hynes, R.O. J. Biol. Chem. 1982, 275(5), 2343–9.
  6. Wang, R.; Li, M.; Zhuang, X.; Hu, B.; Yao, E.; Song, X.; Li, S.; Song, Y.; Zhonghua, F.; Yu, F.Z. Zhonghua Fangshe Yixue Yu Fanghu Zazhi 1997, 17(4), 250–252.
  7. Stoklasova, A.; Krizala, J.; Chmelar, V. Experientia 1978, 34(7), 870–871.
  8. Dumetrescu, G.; Dumitrescu, E.; Chriac, C. Pat. ROM No RO71910, 1980.

Share and Cite

MDPI and ACS Style

Angeles, E.; Menconi, I.; Ramírez, A.; Velázquez, A.M.; Camacho, B.; Ordónez, G.; Martínez, I.; Díaz-Barriga, S.; López-Castañares, R. Synthesis of 1,2,5,7-dithiadiazonan-6-ylidenecyanamide. A New Potential Cysteamine Derivate Radioprotector Compound. Molbank 2007, 2007, M550. https://doi.org/10.3390/M550

AMA Style

Angeles E, Menconi I, Ramírez A, Velázquez AM, Camacho B, Ordónez G, Martínez I, Díaz-Barriga S, López-Castañares R. Synthesis of 1,2,5,7-dithiadiazonan-6-ylidenecyanamide. A New Potential Cysteamine Derivate Radioprotector Compound. Molbank. 2007; 2007(3):M550. https://doi.org/10.3390/M550

Chicago/Turabian Style

Angeles, Enrique, Italo Menconi, Alberto Ramírez, Ana María Velázquez, Brígida Camacho, Gerardo Ordónez, Ignacio Martínez, Sandra Díaz-Barriga, and Rafael López-Castañares. 2007. "Synthesis of 1,2,5,7-dithiadiazonan-6-ylidenecyanamide. A New Potential Cysteamine Derivate Radioprotector Compound" Molbank 2007, no. 3: M550. https://doi.org/10.3390/M550

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop